Bruker Corp
BRKR
59.72
-0.78
-1.29%
Bruker Corp
US · BRKR
#1504 by market cap
Listed 1970
59.72
-0.78
-1.29%
Live - 5344 symbols - heartbeat 159s ago
· 2026-10-08 04:17
Pre-market
60.06
+0.57%
After-hours
60.45
+1.22%
Overnight
59.00
-1.21%
- Market cap
- 9.10B
- P/E (TTM)i
- -85.31
- P/Bi
- 3.79
- EPSi
- -0.15
- Div yieldi
- 0.33%
- 52W posi
- 79%
Reader sentiment
Are you bullish or bearish on BRKR?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 7 analysts
Buy
Avg price target
63.00 +5.5%
Price target rangecurrent 59.72
Low53.00
Avg63.00
High80.00
Buy 86%
Hold 14%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-10-01 | Guggenheim | -- | BUY | 72.00 |
| 2026-09-29 | Leerink Partners | -- | BUY | 80.00 |
| 2026-08-25 | Barclays | -- | BUY | 58.00 |
| 2026-08-06 | J.P. Morgan | -- | BUY | 60.00 |
| 2026-08-05 | Wells Fargo | -- | BUY | 55.00 |
| 2026-08-05 | BofA Securities | -- | BUY | -- |
| 2026-08-05 | Citi | -- | HOLD | 53.00 |
| 2026-08-04 | Guggenheim | -- | BUY | 70.00 |
| 2026-07-08 | Citi | -- | HOLD | 60.00 |
| 2026-06-29 | Guggenheim | -- | BUY | 70.00 |
| 2026-06-24 | Barclays | -- | BUY | 60.00 |
| 2026-06-08 | J.P. Morgan | -- | BUY | 65.00 |
| 2026-06-02 | BofA Securities | -- | BUY | 65.00 |
| 2026-06-01 | Wolfe Research | -- | HOLD | -- |
| 2026-05-08 | Stifel | -- | HOLD | 45.00 |
| 2026-05-07 | Citi | -- | HOLD | 44.00 |
| 2026-05-07 | Barclays | -- | BUY | 53.00 |
| 2026-05-07 | RBC Capital | -- | HOLD | 45.00 |
| 2026-05-06 | Guggenheim | -- | BUY | 50.00 |
| 2026-04-14 | Barclays | -- | BUY | 45.00 |
| 2026-04-07 | Citi | -- | HOLD | 40.00 |
| 2026-03-31 | BofA Securities | -- | BUY | -- |
| 2026-03-30 | Guggenheim | -- | BUY | 50.00 |
| 2026-03-02 | BofA Securities | -- | BUY | 49.00 |
| 2026-02-13 | UBS | -- | HOLD | 40.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Buy
Analyst consensus
Buy
All 2 views agree: bullish.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Mixed
1
■ Upgrades■ Downgrades
- 0 upgrades vs 1 downgrade among tracked analyst rating changes.
- Most recent: Wolfe Research moved from Buy to Hold on 2026-06-01.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-06-01 | Wolfe Research | BUY → HOLD | -- |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-04 | -- | ±12.82% | -21.79% (beat) |
| 2026/Q1 | 2026-05-06 | -- | ±8.85% | +11.29% (beat) |
| 2025/Q4 | 2026-02-12 | -- | ±7.45% | -11.60% (beat) |
| 2025/Q3 | 2025-11-03 | -- | ±12.49% | -0.59% (in line) |
| 2025/Q2 | 2025-08-04 | -- | ±12.18% | -8.62% (in line) |
| 2025/Q1 | 2025-05-07 | -- | ±12.45% | +3.32% (in line) |
| 2024/Q4 | 2025-02-13 | -- | ±9.95% | -0.97% (in line) |
| 2024/Q3 | 2024-11-05 | -- | ±9.43% | +3.35% (in line) |
| 2024/Q2 | 2024-08-06 | -- | ±10.57% | -2.17% (in line) |
| 2023/Q4 | 2024-02-13 | -- | ±7.91% | +8.77% (beat) |
| 2023/Q3 | 2023-11-02 | -- | ±5.28% | -1.05% (in line) |
| 2023/Q2 | 2023-08-03 | -- | ±8.77% | -4.83% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 04:17:50 · For reference only, not investment advice and not tailored to your situation.